FREE SHIPPING ON ORDERS OVER $150

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

$22.42

Quantity
- +
Description

Van Beek, Lwik, & Papapoulos, 2002)

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

Glucose sensing mediated by portal glucagon-like Peptide 1 receptor is markedly impaired in insulin-resistant obese animals

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

Research Data Data above is summarised from preclinical and in-vitro literature and is provided for research orientation only

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

A versatile, solvent-free methodology for the functionalisation of carbon nanotubes

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

The role of the gut microbiota-brain axis in PD pathogenesis is increasingly well-defined

igf-1 lr3 clinical trial humans RUO Recombinant Human Protein QK041 - Recombinant human/bovine/porcine IGF-1

You may also like

recommand products